|
De Villiers EM, Gunst K, Stein H, Scherubl H. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences
International Journal of Cancer
Scherubl H, Zeitz M. Esophageal cancer
New England Journal of Medicine
Sutter A, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H. Activation of ERK1/2 by ligands of the peripheral benzodiazepine receptor (PBR): Inhibition increases sensitivity of esophageal cancer cells to PBR ligands
Biochemical Pharmacology
Höpfner M, Maaser K, Theiss A, Lenz M, Sutter A, Kashtan H, von Lampe B, Riecken E-O, Zeitz M, Scherubl H. Hypericin activated by an incoherent light source has photodynamic effects on oesophageal cancer cells
International Journal of Colorectal Diseases
Maaser K, Däubler P, Barthel B, Heine B, von Lampe B, Stein H, Hoffmeister B, Scherer H, Scherubl H. Esophageal squamous cell neoplasia in head and neck cancer patients. Upregulation of COX-2 during carcinogenesis
British Journal of Cancer
Scherubl H, Sutter A, Zeitz M. NSAIDs and esophageal cancer
Gastroenterology
Grabowski P, Kühnel T, Mühr-Wilkenshoff F, Heine B, Stein H, Höpfner M, Germer C, Scherubl H. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma
British Journal of Cancer
Hopfner M, Sutter A, Gerst B, Zeitz M, Scherubl H. A novel approach in the treatment of neuroendocrine gastrointestinal tumors. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)
British Journal of Cancer
Maaser K, Grabowski P, Sutter A, Barthel B, Foss HD, Berger G, Carayon P, Kühnel T, Gavish M, Zeitz M, Scherubl H. Overexpression of the peripheral-type benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer
Clinical Cancer Research
Scherubl H, Scherer H, Hoffmeister B. Second esophageal cancers in head and neck cancer patients
New England Journal of Medicine
Dr. Hans Scherübl
Dirección profesional:
Hindenburgdamm 30, 12200 Berlin. Germany
|
